VIB-UGent Center for Medical Biotechnology

Science director: Nico Callewaert

Research at the VIB-UGent Center for Medical Biotechnology pushes the boundaries of biomolecular / bioinformatics research and engineering technologies.

The Center translates its novel technologies and insights to widely applicable research tools, vaccines, diagnostics and pharmaceuticals.

The Center educates and trains the next generation of medical biotechnology researchers and informs the public on the impact of biotechnology on human health.

MBC’s focus is to develop new and innovative molecular tools and technologies to challenge human health problems. An emerging and fascinating research theme at MBC is the development and production of new biopharmaceuticals and vaccines (movie). MBC is currently working on new applications in tuberculosis research, cancer treatment, antiviral immunity and others.

Nico Callewaert explains his strategy

VIB-UGent Center for Medical Biotechnology

Scientists & research:

  • Nico Callewaert Lab
    glycoconjugates - biological systems engineering - glycan profiling - post-translational modifications - glycomics
  • Proteomics Expertise Lab
    mass spectrometry-based protein technologies
  • Sven Eyckerman Lab
    interactomics, protein complexes, signal transduction
  • Kris Gevaert Lab
    COFRADIC - gel-free proteomics - bioinformatics - protein processing - protein modification
  • Lennart Martens Lab
    computational - proteomics - degradomics - interactomics - systems biology
  • Xavier Saelens Lab
    influenza - viral growth and purification - recombinant vaccines - oligomerization - antiviral immunity
  • Jan Tavernier Lab
    signal transduction - protein interactions - leptin - cytokine receptors - innate immune responses


VIB-UGent Center for Medical Biotechnology
Albert Baertsoenkaai 3  9000 GENT BELGIUM
+32 9 264 93 17
+32 9 264 94 90

Click here for an overview of the supporting staff ​​

Hosting: VIB Proteomics Core

VIB Proteomics Core provides mass spectrometry-driven proteome analyses, and our services include, but are not limited to:

  • differential proteome analysis, both using stable isotopes as well as label-free,
  • analysis of protein modifications such as phosphorylation, ubiquitination, acetylation and protein processing by proteases,
  • characterization of isolated protein complexes using affinity purification-mass spectrometry (AP-MS),
  • protein quantification using targeted proteomics,
  • protein mass determination, and
  • identification of protein partners binding to drugs or small molecules (chemical proteomics).

For more information:

VIB Proteomics Core